* Showcases AllplexTM HPV products designed to test for 14 high-risk HPV genotypes * Advocates HPV testing for early diagnosis and prevention of cervical cancer * Aims to accelerate the widespread adoption of syndromic PCR testing to create “a world free from all diseases” Seegene Inc. (KQ096530), a leading South Korean company providing...
* Strategic alliance aims to foster collaboration with researchers working in various disease fields by using best-in-class PCR diagnostic technology * Companies will facilitate C-level cooperation, strengthening the partnership for the SG OneSystem™ business (Seegene’s technology-sharing business) Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR...
* Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to 'a world free from all diseases and future pandemics' * Digitally enhance Seegene's automated diagnostic reagent development system with the integration of Microsoft Azure AI solutions * A declaration ceremony within 1H...
* Introduces NovaplexTM MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Clade II * Adheres to the WHO issued target product profiles and provides accurate detection of viral strains * Offer healthcare professtional with a critical tool in their research on...
• The first tri-party executive roundtable was held in London to strengthen synergies for Seegene’s vision of creating ‘a world free from diseases’ • Preliminary results of product development automation and statistical analysis of syndromic test results powered with Microsoft’s AI technology were showcased • Global experts and scientists participated in...